Molecular Characterization of β-Thalassemia in the Czech and Slovak Populations: Mediterranean, Asian and Unique Mutations

References

• Loukopoulos D, Kollia P. Worldwide distribution of β thalassemia. In: Steinberg MH, Forget BG, Higgs DR, Nagel RL, Eds. Disorders of Hemoglobin Genetics, Pathophysiology, and Clinical Management. New York, NY: Cambridge University Press. 2001:861–877
   Google Scholar
• Laig M, Pape M, Hundrieser J, Flatz G. Mediterranean types of β-thalassemia in the German population. Hum Genet. 1990;85(1):135–137
   PubMed Web of Science ®Google Scholar
• Hall GW, Barnetson RA, Thein SL. β Thalassaemia in the indigenous British population. Br J Haematol. 1992;82(3):584–588
   PubMed Web of Science ®Google Scholar
• Indrak K, Brabec V, Indrakova J, et al. Molecular characterization of β-thalassemia in Czechoslovakia. Hum Genet. 1992;88(4):399–404
   PubMed Web of Science ®Google Scholar
• Ringelhann B, Szelenyi JG, Horanyi M, et al. Molecular characterization of β-thalassemia in Hungary. Hum Genet. 1993;92(4):385–387
   PubMed Web of Science ®Google Scholar
• Heusterspreute M, Derclaye I, Gala JL, et al. β-Thalassaemia in indigenous Belgian families: Identification of a novel mutation. Hum Genet. 1996;98(1):77–79
   PubMed Web of Science ®Google Scholar
• Vetter B, Schwarz C, Kohne E, Kulozik AE. β-Thalassaemia in the immigrant and non-immigrant German populations. Br J Haematol. 1997;97(2):266–272
   PubMed Web of Science ®Google Scholar
• Maciag M, Plochocka D, Adamowicz-Salach A, et al. Diversity of thalassemia variants in Poland – screening by real-time PCR. Acta Haematol. 2008;120(3):153–157
   PubMed Web of Science ®Google Scholar
• Van Zwieten R, Veldthuis M, Delzenne B, et al. Hemoglobin analyses in The Netherlands reveal more than 80 different variants including six novel ones. Hemoglobin. 2014;38(1):1–7
   PubMed Web of Science ®Google Scholar
• Kohne E, Kleihauer E. Hemoglobinopathies: A longitudinal study over four decades. Dtsch Arztebl Int. 2010;107(5):65–71
   PubMed Web of Science ®Google Scholar
• Thein SL. Dominant β thalassaemia: Molecular basis and pathophysiology. Br J Haematol. 1992;80(3):273–277
   PubMed Web of Science ®Google Scholar
• Mojzikova R, Dolezel P, Pavlicek J, et al. Partial glutathione reductase deficiency as a cause of diverse clinical manifestations in a family with unstable hemoglobin (Hemoglobin Hana, β63(E7) His-Asn). Blood Cells Mol Dis. 2010;45(3):219–222
   PubMed Web of Science ®Google Scholar
• Barbour VM, Tufarelli C, Sharpe JA, et al. α-Thalassemia resulting from a negative chromosomal position effect. Blood. 2000;96(3):800–807
   PubMed Web of Science ®Google Scholar
• Tufarelli C, Stanley JA, Garrick D, et al. Transcription of antisense RNA leading to gene silencing and methylation as a novel cause of human genetic disease. Nat Genet. 2003;34(2):157–165
   PubMed Web of Science ®Google Scholar
• Lanikova L, Kucerova J, Indrak K, et al. β-Thalassemia due to intronic LINE-1 insertion in the β-globin gene (HBB): Molecular mechanisms underlying reduced transcript levels of the β-globin(L1) allele. Hum Mutat. 2013;34(10):1361–1365
   PubMed Web of Science ®Google Scholar
• Divoky V, Gu L-H, Indrak K, et al. A new β0-thalassaemia nonsense mutation (codon 112, T→A) not associated with a dominant type of thalassaemia in the heterozygote. Br J Haematol. 1993;83(3):523–524
   PubMed Web of Science ®Google Scholar
• Kynclova E, Divoky V, Kovarikova L, et al. [New β0-thalassaemic insertion mutation (CD 7/8, +G) in a Slovak family, associated with the Mediterranean haplotype IX]. Vnitr Lek. 1999;45(3):151–154
   PubMedGoogle Scholar
• Indrak K, Indrakova J, Kutlar F, et al. Compound heterozygosity for a β0-thalassemia (frameshift codons 38/39; −C) and a nondeletional Swiss type of HPFH (A→C at NT −110, Gγ) in a Czechoslovakian family. Ann Hematol. 1991;63(2):111–115
   PubMed Web of Science ®Google Scholar
• Kynclova E, Kovarikova L, Fajkosova P, et al. [Haplotypes of the β-globulin locus in Czechs and Slovaks with β-thalassemia and structurally variant hemoglobins]. Vnitr Lek. 1998;44(9):518–523
   PubMedGoogle Scholar
• Fabryova V, Babusik P, Laluhova-Striezencova Z, et al. Nineteen years study of β-thalassaemia in Slovakia. Cent Eur J Public Health. 2012;20(4):239–243
   PubMed Web of Science ®Google Scholar
• Alexander J. Slovakia. In: Frucht RC, Ed. Eastern Europe: An Introduction to the People, Lands, and Culture, Vol. 2. Santa Barbara, CA: ABC-CLIO. 2005:283–328
   Google Scholar
• Miller D. The Czech Republic. In: Frucht RC, Ed. Eastern Europe: An Introduction to the People, Lands, and Culture, Vol. 2. Santa Barbara, CA: ABC-CLIO. 2005:203–282
   Google Scholar
• Giardine B, Borg J, Viennas E, et al. Updates of the HbVar database of human hemoglobin variants and thalassemia mutations. Nucleic Acids Res. 2014;42(Database issue):D1063–D1069. (http://globin.cse.psu.edu)
   PubMed Web of Science ®Google Scholar
• Kutlar A, Huisman THJ. Detection of hemoglobinopathies. In: Hommes FA, Ed. Techniques in Diagnostic Human Biochemical Genetics: A Laboratory Manual. New York, NY: Wiley-Liss. 1991:519–560
   Google Scholar
• Urrechaga E, Borque L, Escanero JF. The role of automated measurement of RBC subpopulations in differential diagnosis of microcytic anemia and β-thalassemia screening. Am J Clin Pathol. 2011;135(3):374–379
   PubMed Web of Science ®Google Scholar
• Indrak K, Fei Y-J, Li H-W, et al. A Czechoslovakian teenager with Hb E-β0-thalassemia [IVS-I-1 (G→A)] complicated by the presence of an α-globin gene triplication. Ann Hematol. 1991;63(1):42–44
   PubMed Web of Science ®Google Scholar
• Giambona A, Vinciguerra M, Cannata M, et al. The genetic heterogeneity of β-globin gene defects in Sicily reflects the historic population migrations of the island. Blood Cells Mol Dis. 2011;46(4):282–287
   PubMed Web of Science ®Google Scholar
• Modell B, Darlison M, Birgens H, et al. Epidemiology of haemoglobin disorders in Europe: An overview. Scand J Clin Lab Invest. 2007;67(1):39–69
   PubMed Web of Science ®Google Scholar
• Henderson S, Timbs A, McCarthy J, et al. Incidence of haemoglobinopathies in various populations – the impact of immigration. Clin Biochem. 2009;42(18):1745–1756
   PubMed Web of Science ®Google Scholar
• Makhoul NJ, Wells RS, Kaspar H, et al. Genetic heterogeneity of β thalassemia in Lebanon reflects historic and recent population migration. Ann Hum Genet. 2005;69(Pt 1):55–66
   PubMed Web of Science ®Google Scholar
• Villegas A, Ropero P, Gonzalez FA, et al. The thalassemia syndromes: Molecular characterization in the Spanish population. Hemoglobin. 2001;25(3):273–283
   PubMed Web of Science ®Google Scholar
• Kountouris P, Lederer CW, Fanis P, et al. IthaGenes: An interactive database for haemoglobin variations and epidemiology. PLoS One. 2014;9(7):e103020
   PubMed Web of Science ®Google Scholar
• Bennani C, Bouhass R, Perrin-Pecontal P, et al. Anthropological approach to the heterogeneity of β-thalassemia mutations in northern Africa. Hum Biol. 1994;66(3):369–382
   PubMed Web of Science ®Google Scholar
• Pacheco P, Loureiro P, Faustino P, Lavinha J. Haplotypic heterogeneity of β-thalassaemia IVS I-1 (G→A) mutation in southern Portugal. Br J Haematol. 1996;94(4):767
   PubMed Web of Science ®Google Scholar
• Antonarakis SE, Kazazian HH, Orkin SH. DNA polymorphism and molecular pathology of the human globin gene clusters. Hum Genet. 1985;69(1):1–14
   PubMed Web of Science ®Google Scholar
• Samara M, Chiotoglou I, Kalamaras A, et al. Large-scale population genetic analysis for hemoglobinopathies reveals different mutation spectra in central Greece compared to the rest of the country. Am J Hematol. 2007;82(7):634–636
   PubMed Web of Science ®Google Scholar
• Flatz G, Wilke K, Syagailo YV, et al. β-Thalassemia in the German population: Mediterranean, Asian and novel mutations. Hum Mutat. 1999;13(3):258
   PubMedGoogle Scholar
• Aguilar Martinez P, Angastiniotis M, Eleftheriou A, et al. Haemoglobinopathies in Europe: Health & migration policy perspectives. Orphanet J Rare Dis. 2014;9:97
   PubMed Web of Science ®Google Scholar
• Thein SL. Molecular genetics of β thalassaemia. In: McArthur JR, Lee SH, Wong JEL, Ong YW, Eds. Education Programme of the 26th Congress of the International Society of Haematology, Singapore, August 25-29, 1996. Singapore: International Society of Haematology. 1996:236–240
   Google Scholar
• Thein SL. Genetic insights into the clinical diversity of β thalassaemia. Br J Haematol. 2004;124(3):264–274
   PubMed Web of Science ®Google Scholar
• Sollaino MC, Paglietti ME, Perseu L, et al. Association of α globin gene quadruplication and heterozygous β thalassemia in patients with thalassemia intermedia. Haematologica. 2009;94(10):1445–1448
   PubMed Web of Science ®Google Scholar
• Schwartz E, Goltsov AA, Kaboev OK, et al. A novel frameshift mutation causing β-thalassaemia in Azerbaijan. Nucleic Acids Res. 1989;17(10):3997
   PubMed Web of Science ®Google Scholar
• Solovyev GY, Goltsov AA, Surin VL, et al. Molecular nature of mutations causing β0-thalassaemia in Azerbaijan. Biomed Sci. 1990;1(3):300–304
   PubMedGoogle Scholar
• Çürük MA, Yüreğir GT, Asadov CD, et al. Molecular characterization of β-thalassemia in Azerbaijan. Hum Genet. 1992;90(4):417–419
   PubMed Web of Science ®Google Scholar
• Fei Y-J, Stoming TA, Kutlar A, et al. One form of inclusion body β-thalassemia is due to a GAA→TAA mutation at codon 121 of the β chain. Blood. 1989;73(4):1075–1077
   PubMed Web of Science ®Google Scholar
• Thein SL, Hesketh C, Taylor P, et al. Molecular basis for dominantly inherited inclusion body β-thalassemia. Proc Natl Acad Sci USA. 1990;87(10):3924–3928
   PubMed Web of Science ®Google Scholar
• Yamamoto Ku, Yamamoto Ki, Hattori Y, et al. Two β-thalassemia mutations in Japan: Codon 121 (GAA→TAA) and IVS-I-130 (G→C). Hemoglobin. 1992;16(4):295–302
   PubMed Web of Science ®Google Scholar
• Giordano PC, Harteveld CL, Michiels JJ, et al. Phenotype variability of the dominant β-thalassemia induced in four Dutch families by the rare cd121 (G→T) mutation. Ann Hematol. 1998;77(6):249–255
   PubMed Web of Science ®Google Scholar
• Cao A, Galanello R. β-Thalassemia. Genet Med Off J Am Coll Med Genet. 2010;12(2):61–76
   Google Scholar
• Rivella S. β-Thalassemias: Paradigmatic diseases for scientific discoveries and development of innovative therapies. Haematologica. 2015;100(4):418–430
   PubMed Web of Science ®Google Scholar
• Divoky V, Svobodova M, Indrak K, et al. Hb Hradec Kralove (Hb HK) or α2β2115(G17)Ala→Asp, a severely unstable hemoglobin variant resulting in a dominant β-thalassemia trait in a Czech family. Hemoglobin. 1993;17(4):319–328
   PubMed Web of Science ®Google Scholar
• Popovich BW, Rosenblatt DS, Kendall AG, Nishioka Y. Molecular characterization of an atypical β-thalassemia caused by a large deletion in the 5′ β-globin gene region. Am J Hum Genet. 1986;39(6):797–810
   PubMed Web of Science ®Google Scholar
• Waye JS, Eng B, Patterson M, et al. Novel β-thalassemia mutation in a β-thalassemia intermedia patient [poly A (AATAAA→GATAAA)]. Hemoglobin. 2001;25(1):103–105
   PubMed Web of Science ®Google Scholar
• Thein SL. The molecular basis of β thalassemia. Cold Spring Harb Perspect Med. 2013;3(5):a011700
   PubMed Web of Science ®Google Scholar
• Gallienne AE, Dreau HMP, Schuh A, et al. Ten novel mutations in the erythroid transcription factor KLF1 gene associated with increased fetal hemoglobin levels in adults. Haematologica. 2012;97(3):340–343
   PubMed Web of Science ®Google Scholar
• Sutton M, Bouhassira EE, Nagel RL. Polymerase chain reaction amplification applied to the determination of β-like globin gene cluster haplotypes. Am J Hematol. 1989;32(1):66–69
   PubMed Web of Science ®Google Scholar
• Pritchard CC, Tait JF, Buller-Burckle AM, Mikula M. Annotation error of a common β0-thalassemia mutation (619 bp-deletion) has implications for molecular diagnosis. Am J Hematol. 2010;85(12):978
   PubMed Web of Science ®Google Scholar